Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
The 3 Most Undervalued Pharma Stocks to Buy in September 2023
04:30pm, Thursday, 14'th Sep 2023
It's been a rough year to invest in pharma stocks. The industry is adjusting to a sector that is less reliant on Covid-19 vaccines and is adapting to the effects of inflation as well as pressure from
Bristol Myers plans to double experimental treatments to expand research pipeline
08:48am, Thursday, 14'th Sep 2023
Bristol Myers Squibb said on Thursday it plans to double the number of treatments it is testing in clinical trials, with a focus on cell therapies, over the next 18 months, as it contends with increas
2 Undervalued Dividend Stocks to Buy Now
09:30am, Wednesday, 13'th Sep 2023
Top-shelf dividend stocks tend to trade at hefty premiums. Amgen and Bristol Myers Squibb are two clear exceptions to this general rule of thumb.
Bristol Myers' (BMY) Pulmonary Fibrosis Drug Positive in Phase II
01:32pm, Monday, 11'th Sep 2023
Bristol Myers (BMY) posts encouraging data from a phase II study in progressive pulmonary fibrosis.
The 3 Best Pharma Stocks to Buy Now: September 2023
09:14am, Friday, 08'th Sep 2023
The pharmaceutical sector will always be a sector in constant evolution and growth. As technology advances, the companies that make life in this sector will always be applying it, as well as implement
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
02:24pm, Wednesday, 06'th Sep 2023
Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood cancer drug Pomalyst for years after it shoul
Judge withdraws from Medicare drug price case after stock ownership is revealed
05:23pm, Friday, 01'st Sep 2023
Judge Thomas Rose of the U.S. District Court for the Southern District of Ohio withdrew from a case that could block Medicare's drug price negotiation program.
How Much Pain Will Lower Medicare Prices Cause for Pharma Stocks?
07:01am, Friday, 01'st Sep 2023
Major pharmaceutical companies including Johnson & Johnson NYSE: JNJ, Novartis AG NYSE: NVS, Bristol-Myers Squibb (NYSE: BMY), Merck & Co., Inc. NYSE: MRK, Eli Lilly & Co. NYSE: LLY and Amgen In
Bristol Myers Squibb to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference
06:59am, Friday, 01'st Sep 2023
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #BMS--Bristol Myers Squibb to Participate in the Morgan Stanley 21st Annual Global Healthcare Conference.
Medicare's First Price Negotiation List Targets Expensive Drugs (Revised)
04:31am, Thursday, 31'st Aug 2023
The negotiations with participating drug companies are likely to happen in 2023 and 2024 with the negotiated prices, if any, going into effect in 2026.
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
01:48pm, Wednesday, 30'th Aug 2023
Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.
Multiple Reasons to Keep Off This Pharma Stock
01:42pm, Wednesday, 30'th Aug 2023
Bristol-Myers Squibb Co (NYSE:BMY) is down 0.7% to trade at $62.42 at last check, after the Biden administration included the pharmaceutical name's blood thinner Eliquis in its list of 10 prescript
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
05:00pm, Tuesday, 29'th Aug 2023
The Biden Administration just announced the 10 drugs that will be first included in Medicare price negotiations. Several big drugmakers could be affected, with Johnson & Johnson and Bristol Myers Squi
The technical trade: T, BMY & DLR
03:26pm, Tuesday, 29'th Aug 2023
Katie Stockton, Fairlead Strategies founder, joins 'Power Lunch' to discuss the technical support for AT&T, Bristol-Myers Squibb and Digital Realty Trust.
Cantor's Louise Chen breaks down new Medicare drug pricing negotiations
03:02pm, Tuesday, 29'th Aug 2023
Louise Chen, Cantor Fitzgerald, joins 'Power Lunch' to discuss Medicare drug priced ahead of Biden's news conference on the negotiations.
